In the mid- to late 1970s, recombinant deoxyribonucleic acid methods for cloning and expressing genes in E. coli were under intense development. The important question had become: Can humans design and chemically synthesize novel genes that function in bacteria? This question was answered in 1978 and in 1979 with the successful expression in E. coli of 2 mammalian hormones, first somatostatin and then human insulin. The successful production of human insulin in bacteria provided, for the first time, a practical, scalable source of human insulin and resulted in the approval, in 1982, of human insulin for the treatment of diabetics. In this short review, I give my personal view of how the making, cloning, and expressing of human insulin genes was accomplished by a team of scientists led by Keiichi Itakura, Herbert W. Boyer, and myself.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Riggs, A. D. (2021, June 1). Making, cloning, and the expression of human insulin genes in bacteria: The path to humulin. Endocrine Reviews. Endocrine Society. https://doi.org/10.1210/endrev/bnaa029